Stay updated on Isatuximab for High-Risk Smoldering Myeloma Clinical Trial
Sign up to get notified when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.

Latest updates to the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page
- CheckyesterdayNo Change Detected
- Check9 days agoChange DetectedA new revision entry (v3.6.4) was added to the record history and the previous revision (v3.6.3) was removed, indicating an administrative update to the page's revision history.SummaryDifference0.1%

- Check16 days agoNo Change Detected
- Check23 days agoNo Change Detected
- Check30 days agoChange DetectedThe history entry now shows Revision: v3.6.3 in place of the previous v3.6.2, signaling a new version of the record page. This reflects an update to the page metadata and navigation history rather than substantive study content.SummaryDifference0.1%

- Check37 days agoChange DetectedThe record history page shows a new revision tag (v3.6.2) replacing the previous v3.6.0, indicating a template or UI update to the history view. This does not alter any study data or listed records.SummaryDifference0.1%

- Check51 days agoChange DetectedThe recruitment status changes to no longer looking for participants. The page revision is updated to v3.6.0 (from v3.5.5).SummaryDifference0.2%

- Check58 days agoChange DetectedThe page history now lists Revision: v3.5.5 replacing the previous v3.5.4, indicating a new revision of the record.SummaryDifference0.1%

- Check80 days agoChange DetectedA new revision entry (v3.5.4) was added to the study record history, and the previous revision (v3.5.3) was removed from the history listing.SummaryDifference0.1%

Stay in the know with updates to Isatuximab for High-Risk Smoldering Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Isatuximab for High-Risk Smoldering Myeloma Clinical Trial page.